Skip to main content

Matthew David, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when CorMedix Inc. publishes a filing, an earnings call transcript or a press release.

Get CRMD alerts

About Matthew David, M.D.

Matthew David, M.D. is recorded as CEO at CorMedix Inc. (CRMD) since October 4, 2021. CorMedix Inc. reported in an 8-K filed October 5, 2021 that Matthew David, M.D. was appointed interim Chief Executive Officer, effective October 4, 2021. CorMedix Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CorMedix Inc. includes Joseph Todisco (CEO, Chairman and Board Member), Matt David, M.D. (CEO), Robert W. Cook (CFO) and 7 others.

“Matthew David, M.D., the Company’s current Chief Financial Officer, will serve as interim Chief Executive Officer, effective immediately, until a new Chief Executive Officer is appointed.”
CorMedix Inc. Form 8-K, filed October 5, 2021 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

CEO

2021-10-04–present

Leadership on record at CorMedix Inc.

Recent activity